BSP Pharmaceuticals
June 23, 2026
Theater 3
Type: Company Presentation
Focus Area:
Oncology
BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a strategic interest in specific therapeutic areas.
In a campus of approximately 60 acres, with approximately 650,000 sqf built surface, the facility is designed to handle conventional small molecules, Biologics and ADCs (from Conjugation to Fill Finish) and very much focused on innovative compounds.
With full containment facility, applying the most advanced and safe technologies, BSP can offer a wide range of services for Pre-Clinical, Clinical and Commercial supply in compliance with the highest Quality requirements.
BSP is positioned as a centre of excellence and a valued strategic partner among those small and large pharma and biotech companies with an advanced outsourcing process for strategic products with a high technological content.
Company HQ City:
Latina Scalo (LT)
Company HQ State:
Latium
Company HQ Country:
Italy
Year Founded:
2006
Lead Product in Development:
na
CEO
Aldo Braca
Development Phase of Lead Product
Other/Not Applicable
Number of Unlicensed Products Looking for Licensing
na
When you expect your next catalyst update?
na
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}